相关实验视频

Updated: Jun 13, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

在三阴性乳腺癌中,暂时的拼接抑制会导致持续的DNA损伤和化疗脆弱性

Cinzia Caggiano¹, Valerio Petrera², Miriana Ferri²

¹Department of Neuroscience, Section of Human Anatomy, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy; GSTeP Organoids Research Core Facility, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, 00168 Rome, Italy.

|September 14, 2024

概括

准U2小核核核蛋白粒子 (snRNP) 复合体可以克服三阴性乳腺癌 (TNBC) 中的化疗耐药性. 抑制U2 snRNP会导致DNA损伤,并在TNBC模型中提高药物的有效性.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

三阴性乳腺癌 (TNBC) 是一种具有攻击性的亚型,以初始化疗敏感性而闻名,但经常获得耐药性.
获得的耐药性导致疾病进展和较差的患者结果,突出需要新的治疗策略.

研究的目的:

确定调节三阴性乳腺癌化疗疗效能的新目标.
为了研究结合体U2小核核核蛋白粒子 (snRNP) 复合体在化疗耐药性中的作用.

主要方法:

利用TNBC细胞系和器官来评估暂时U2 snRNP抑制的影响.
分析了DNA损伤反应 (DDR) 基因放松调节和蛋白质表达后的拼接抑制.
评估了U2 snRNP抑制与基药物和PARP抑制剂的联合细胞毒性作用.

主要成果:

暂时的U2 snRNP抑制诱导了TNBC细胞和有机体中的持续DNA损伤,无论同源重组能力如何.
抑制U2 snRNP导致DDR基因的广泛放松调节,特别是那些具有小外子的基因.
拼接抑制导致DDR蛋白持续抑制,并增强了类药物和PARP抑制剂的细胞毒性.

结论:

在三阴性乳腺癌中,U2 snRNP复合体是化疗疗效能的关键调节器.
准U2 snRNP是一个有前途的策略,可以提高TNBC当前化疗的有效性.
利用U2 snRNP为克服侵袭性乳腺癌治疗耐药性的新疗法提供了新的治疗途径.

关键词:

CP: 癌症癌症癌症造成的DNA损伤是DNA损伤.综合治疗是一种治疗.同类的重组组合.塑乙烯酸 B 类的拼接抑制剂拼接抑制剂有针对性的治疗.三重阴性乳腺癌是什么

更多相关视频

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

DNA Damage can Stall the Cell Cycle

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

DNA Damage Can Stall the Cell Cycle

DNA Damage Can Stall the Cell Cycle

Translesion DNA Polymerases

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...

Nucleotide Excision Repair

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...